Summary: Duloxetine is a balanced selective serotonin and norepinephrine-reuptake inhibitor available in the United States for the treatment of major depressive disorder (MDD) and diabetic ...
de Filippis, R. and Al Foysal, A. (2024) Case Report: The Role of Monoamine Oxidase Inhibitors in Treating Resistant Depression. Open Access Library Journal, 11, 1-12. doi: 10.4236/oalib.1112369 .
“The condition is commonly associated with the use of certain medications, particularly those that enhance serotonin activity, such as selective serotonin reuptake inhibitors (SSRIs), ...
Concomitant treatment with triptans with serotonin–norepinephrine reuptake inhibitors (SNRIs; venlafaxine) can cause serious serotonin syndrome. In July 2006, the FDA issued an alert on ...